Abeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene Therapy
Abeona Therapeutics Inc. (NASDAQ:ABEO) is one of the stocks under $10 to buy now.
Abeona Therapeutics Inc. (ABEO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.71 | 11,000 | $51,799.00 | 82,857 | 2024-05-16 | Filing | |
| $3.20 | 10,000 | $32,000.00 | 538,260 | 2024-04-25 | Filing | |
| $3.28 | 7,550 | $24,764.00 | 78,323 | 2024-04-26 | Filing | |
| $3.24 | 8,600 | $27,864.00 | 188,718 | 2024-04-25 | Filing | |
| $3.14 | 5,608 | $17,609.12 | 233,868 | 2024-04-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.64 | 1,502 | $9,974.63 | 477,666 | 2025-07-22 | Filing | |
| $5.86 | 13,093 | $76,668.68 | 120,479 | 2025-07-09 | Filing | |
| $5.86 | 69,420 | $406,502.69 | 1,234,341 | 2025-07-09 | Filing | |
| $5.86 | 25,411 | $148,799.19 | 479,168 | 2025-07-09 | Filing | |
| $5.82 | 5,176 | $30,147.09 | 145,436 | 2025-07-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,507,023 | $14,239,890 | 0% | |
| 2. | 1,105,862 | $6,282,200 | 0% | |
| 3. | 560,770 | $3,185,174 | 0.38% | |
| 4. | 558,584 | $3,172,757 | 0.16% | |
| 5. | 548,057 | $3,112,964 | 0% |
News See All
10 Stocks Under $10 to Buy Now
Earlier on July 1, Peter Kraus, Aperture Investors chairman and CEO, joined 'Squawk Box' on CNBC to suggest that the small and mid-cap area is a place for significant growth.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2025 Earnings Call Transcript
Operator: Good day and welcome to the Abeona Therapeutics First Quarter 2025 Conference Call.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Abeona Therapeutics Full Year 2024 Results and Business Update Conference Call. At this time all participants are in a listen-only mode.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Abeona Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions]. Please note this conference is being recorded.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Abeona Therapeutics Second Quarter 2023 Update Conference Call [Operator Instructions]. As a reminder, today's conference is being recorded.
5 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 5 best biotech penny stocks to buy now.
10 Best Penny Stocks to Buy in September
As the stock market runs red, investors are wary about spending copious amounts of money and making huge investments amid such macro uncertainty.
5 Biotech Penny Stocks to Buy According to Reddit
In this article, we discuss the 5 biotech penny stocks to buy according to Reddit.
10 Penny Stocks Robinhood Traders are Buying in 2021
In this article, we discuss the 10 penny stocks Robinhood traders are buying in 2021.
Billionaire Hedge Funds
